StocksMedium•19 November 2026•
1 min read
Humana Shares Drop 9% Amid Regulatory Scrutiny of Medicare Programs
Key Facts
1Humana shares fell 9% following reports of increased regulatory scrutiny regarding potential fraud in Medicare Advantage and Medicaid plans.
Humana shares fell 9% following reports of increased regulatory scrutiny regarding potential fraud in Medicare Advantage and Medicaid plans. Benzinga reported that the decline was triggered by a proposed regulatory rule aimed at targeting fraud within government-funded health programs.
Humana closed at $385.78 on November 18, 2026, with the stock reaching a session low of $384.61. The regulatory crackdown has impacted the broader health insurance sector as markets assess the implications of the proposed enforcement actions on industry providers.